Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Capital Employed (2016 - 2025)

Marimed has reported Return on Capital Employed over the past 14 years, most recently at 1.82% for Q4 2025.

  • Quarterly Return on Capital Employed fell 360.0% to 1.82% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.82% through Dec 2025, down 360.0% year-over-year, with the annual reading at 1.94% for FY2025, 366.0% down from the prior year.
  • Return on Capital Employed was 1.82% for Q4 2025 at Marimed, down from 0.28% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 39.3% in Q2 2021 and troughed at 1.82% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 10.42% (2023), against an average of 13.69%.
  • Year-over-year, Return on Capital Employed skyrocketed 17345bps in 2021 and then plummeted -2190bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 28.73% in 2021, then plummeted by -42bps to 16.7% in 2022, then plummeted by -47bps to 8.85% in 2023, then plummeted by -80bps to 1.79% in 2024, then tumbled by -202bps to 1.82% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Return on Capital Employed are 1.82% (Q4 2025), 0.28% (Q3 2025), and 0.11% (Q2 2025).